The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

I wrote earlier this week about Johnson & Johnson’s recall problems. In another blow to J&J’s image, US prosecutors are seeking $1 billion from Johnson & Johnson for off label (unapproved) marketing of its anti-psychotic drug, Risperdal. According to reports, prosecutors are pushing J&J to reach a settlement soon.

Atypical anti-psychotic drugs, like Risperdal, were designed to treat ailments like schizophrenia or bipolar disorder, but have been marketed and used extensively for "off label" or unapproved purposes. These drugs have serious side effects including tardive sykinesia, hyperglycemia, diabetes, pancreatitis, and heart attack.

Check with your physician if you have been prescribed Risperdal or other atypical anti-psychotic drugs.

More Information:

(c) Copyright Brett A. Emison

Comments are closed.

Of Interest